Inogen, Inc. (INGN) News
Track canonical SquawkNews coverage tagged to INGN, Inogen, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
Inogen (NASDAQ: INGN ) lowers FY2026 sales outlook from $366.000 million-$373.000 million to $355.000 million-$361.000 million vs $369.267 million estimate.
EARNINGS | Aug 06, 2026, 08:19 PM UTC
L
Inogen Appoints Andy Reding As COO, Effective On July 6, 2026
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Andy Reding to the newly created role of Chief Opera
EARNINGS | Jul 01, 2026, 08:08 PM UTC